» Prosensa announces Lancet Neurology publication of an exploratory phase II study of Drisapersen Action Duchenne: "Prosensa announces Lancet Neurology publication of an exploratory phase II study (DEMAND II) demonstrating efficacy and safety of drisapersen in patients with Duchenne muscular dystrophy"
'via Blog this'
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment